Aptamer-based proteomic profiling for prognostication in pulmonary arterial hypertension

Lancet Respir Med. 2017 Sep;5(9):671-672. doi: 10.1016/S2213-2600(17)30209-6. Epub 2017 Jun 15.

Authors

Evangelos Giannitsis¹, Matthias Mueller-Hennessen¹, Hugo A Katus²

Affiliations

¹ Department of Internal Medicine III, Cardiology, University Hospital Heidelberg, Heidelberg 69120, Germany.
² Department of Internal Medicine III, Cardiology, University Hospital Heidelberg, Heidelberg 69120, Germany. Electronic address: hugo.katus@med.uni-heidelberg.de.

PMID: 28624387
DOI: 10.1016/S2213-2600(17)30209-6

No abstract available

Publication types

Comment

MeSH terms

Familial Primary Pulmonary Hypertension
Gene Expression Profiling
Humans
Hypertension, Pulmonary*
Proteomics*